TeraPore Technologies, co-founded by Rachel Dorin, Ph.D. ’13, and its novel nanofiltration products are changing how the pharmaceutical industry is reducing risk of harmful virus contamination in biological drugs.
A dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new option, according to results from a multi-center international clinical trial co-led by a Weill Cornell Medicine investigator.
Ashley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.
Nutritionists generally advise everyone to eat more dietary fiber, but a new study suggests that its effects on health can vary, suggesting that recommendations should be tailored to each individual’s gut microbiome.
Intimate partner violence is notoriously underreported and correctly diagnosed at hospitals only around a quarter of the time, but a new method provides a more realistic picture of which groups of women are most affected, even when their cases go unrecorded.
Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.
The transition to menopause is marked by a progressively higher density of estrogen receptors on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study.
A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.